Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05553132 · ClinicalTrials.gov registry record · Phase 1
A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects
A Phase 1 study of Cartilage Defect, sponsored by Daniel B. F. Saris.
- Active
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT05553132 is a Phase 1 study of Cartilage Defect that is active but no longer recruiting, run by Daniel B. F. Saris. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05553132, a Phase 1 study of Cartilage Defect, is active but no longer recruiting, sponsored by Daniel B. F. Saris.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study it to gather information on the safety and side effects of treating cartilage defects with autologous cartilage cells mixed with allogeneic adipose-derived mesenchymal stem cells (AMSCs) in a fibrin glue.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Autologous Chondrocytes in their Pericellular Matrix (Chondrons) Coimplanted with Allogeneic Adipose-Derived Mesenchymal Stromal Cells (AMSCs) in a Fibrin Glue Carrier
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-08-08 |
| Est. Completion | 2026-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05553132
The ClinicalTrials.gov registry entry for NCT05553132 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daniel B. F. Saris, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cartilage Defect appearing as the primary indexed condition, and to 1 intervention - of which Autologous Chondrocytes in their Pericellular Matrix (Chondrons) Coimplanted with Allogeneic Adipose-Derived Mesenchymal Stromal Cells (AMSCs) in a Fibrin Glue Carrier is the first listed.
NCT05553132 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05553132 about?
NCT05553132 is a clinical study titled "A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects". The purpose of this research study it to gather information on the safety and side effects of treating cartilage defects with autologous cartilage cells mixed with allogeneic adipose-derived mesenchymal stem cells (AMSCs) in a fibrin glue.
What is the current status of trial NCT05553132?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2023-08-08. Estimated completion is 2026-12.
What conditions does trial NCT05553132 study?
This clinical trial studies the following conditions: Cartilage Defect.
What interventions are being tested in trial NCT05553132?
The interventions under investigation include: Autologous Chondrocytes in their Pericellular Matrix (Chondrons) Coimplanted with Allogeneic Adipose-Derived Mesenchymal Stromal Cells (AMSCs) in a Fibrin Glue Carrier (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05553132?
This trial is sponsored by Daniel B. F. Saris, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05553132 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.